
Chemotherapy courses after surgery could be cut in half for some colon cancer patients, according to a new global study.
Patients with colon cancer that has spread to the lymph nodes (stage 3) usually get six months of chemotherapy after surgery.
But researchers found that shortening treatment to three months did not affect the chance of cancer returning for many patients. The shorter treatment time also significantly reduced side effects.
“This will change the way we treat patients in the UK. Finding that three months of chemotherapy is as good as six will have a huge impact on the side effects people experience, as well as NHS resource.” – Professor John Bridgewater, University College Hospital.
Source: Cancer Research UK







